Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.63%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
31.97 Down 0.76(2.32%) 4:00PM EDT
|After Hours : 31.97 Down 0.00 (0.01%) 4:41PM EDT
Add to Portfolio
Prev Close:32.73
Open:32.49
Bid:N/A
Ask:42.00 x 200
1y Target Est:44.33
Beta:0.923915
Earnings Date:Oct 28 - Nov 2 (Est.)
Day's Range:31.53 - 33.39
52wk Range:27.92 - 45.45
Volume:901,184
Avg Vol (3m):629,037
Market Cap:1.37B
P/E (ttm):132.11
EPS (ttm):0.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORDown 2.32%1.37B
BIIBDown 2.10%69.92B

Key Statistics

Forward P/E (1 yr):34.75
P/S (ttm):3.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.70
Quarterly EPS Est (Sep-15) :0.15
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.56

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback